Arkolith/Insider Trading/NBRV/Form 4

Bourdow Carrie L.

DirectorNabriva Therapeutics plc (NBRV) · full profile →Form 4 · filed Aug 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1K
Net Open-Market Flow
-$1K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2022Sell(S)9K$0.17$1K10K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-085789) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML